- Home
- SOPA vs GLMD Comparison
SOPA vs GLMD Comparison
Compare SOPA & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOPA
- GLMD
- Stock Information
- Founded
- SOPA 2018
- GLMD 2000
- Country
- SOPA Singapore
- GLMD Israel
- Employees
- SOPA N/A
- GLMD N/A
- Industry
- SOPA EDP Services
- GLMD Biotechnology: Pharmaceutical Preparations
- Sector
- SOPA Technology
- GLMD Health Care
- Exchange
- SOPA Nasdaq
- GLMD Nasdaq
- Market Cap
- SOPA 7.4M
- GLMD 7.5M
- IPO Year
- SOPA 2021
- GLMD 2014
- Fundamental
- Price
- SOPA $1.19
- GLMD $1.49
- Analyst Decision
- SOPA Strong Buy
- GLMD Hold
- Analyst Count
- SOPA 1
- GLMD 1
- Target Price
- SOPA $15.00
- GLMD N/A
- AVG Volume (30 Days)
- SOPA 81.7K
- GLMD 214.5K
- Earning Date
- SOPA 11-14-2025
- GLMD 11-13-2025
- Dividend Yield
- SOPA N/A
- GLMD N/A
- EPS Growth
- SOPA N/A
- GLMD N/A
- EPS
- SOPA N/A
- GLMD N/A
- Revenue
- SOPA $7,522,939.00
- GLMD N/A
- Revenue This Year
- SOPA N/A
- GLMD N/A
- Revenue Next Year
- SOPA $45.16
- GLMD N/A
- P/E Ratio
- SOPA N/A
- GLMD N/A
- Revenue Growth
- SOPA 0.31
- GLMD N/A
- 52 Week Low
- SOPA $0.64
- GLMD $1.15
- 52 Week High
- SOPA $6.75
- GLMD $23.80
- Technical
- Relative Strength Index (RSI)
- SOPA 44.93
- GLMD 51.48
- Support Level
- SOPA $1.18
- GLMD $1.42
- Resistance Level
- SOPA $1.24
- GLMD $1.60
- Average True Range (ATR)
- SOPA 0.07
- GLMD 0.10
- MACD
- SOPA -0.01
- GLMD 0.03
- Stochastic Oscillator
- SOPA 20.83
- GLMD 68.06
About SOPA Society Pass Incorporated
Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with entrepreneurs, the company meets the growing demand for services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Corporate. The company generates the majority of its revenue from the Digital marketing segment.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.